GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adaptive Biotechnologies Corp (NAS:ADPT) » Definitions » Occupancy Rate %

ADPT (Adaptive Biotechnologies) Occupancy Rate % : 0.00% (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Adaptive Biotechnologies Occupancy Rate %?

Occupancy Rate % shows the actual utilization of an inpatient health facility for a given time period.

The historical rank and industry rank for Adaptive Biotechnologies's Occupancy Rate % or its related term are showing as below:

ADPT's Occupancy Rate % is not ranked *
in the Biotechnology industry.
Industry Median:
* Ranked among companies with meaningful Occupancy Rate % only.

Adaptive Biotechnologies Occupancy Rate % Historical Data

The historical data trend for Adaptive Biotechnologies's Occupancy Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adaptive Biotechnologies Occupancy Rate % Chart

Adaptive Biotechnologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Occupancy Rate %
Get a 7-Day Free Trial Premium Member Only

Adaptive BiotechnologiesQuarterly Data
Trend Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Occupancy Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only

Competitive Comparison of Adaptive Biotechnologies's Occupancy Rate %

For the Biotechnology subindustry, Adaptive Biotechnologies's Occupancy Rate %, along with its competitors' market caps and Occupancy Rate % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adaptive Biotechnologies  (NAS:ADPT) Occupancy Rate % Calculation

To calculate Occupancy Rate %, we use inpatient days of care and bed days available. Inpatient days of care is the sum of each daily inpatient census for the year. Bed days available is the maximum number of inpatient days of care that would have been provided if all beds were filled during the year. The formula is:

Occupancy Rate %=( Inpatient Days of Care / Bed Days Available ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adaptive Biotechnologies  (NAS:ADPT) Occupancy Rate % Explanation

Occupancy Rate % is a calculation used to show the actual utilization of an inpatient health facility for a given time period. The occupancy rate reflects the degree to which hospital beds have been utilized even though the number of beds may have changed during the reporting period.

The average occupancy rate of community (that is, non-Federal, short-term general) hospitals is about 76%. We can recognize a hospital with a too-low occupancy rate as inefficient; such a hospital may find it hard to meet its profit goals. However, a constantly high occupancy rate may not be a good sign, either. Very high occupancy rates may reflect that the hospital is under great pressure from medical and labor sources. Thus, a reasonable occupancy rate is more acceptable than a high one.


Adaptive Biotechnologies Occupancy Rate % Related Terms

Thank you for viewing the detailed overview of Adaptive Biotechnologies's Occupancy Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.


Adaptive Biotechnologies Business Description

Traded in Other Exchanges
Address
1165 Eastlake Avenue East, Seattle, WA, USA, 98109
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
Executives
Kyle Piskel officer: Principal Accounting Officer C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102
Harlan S Robins officer: Chief Scientific Officer C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102
Michelle Renee Griffin director 19723 NE 65TH LANE, KIRKLAND WA 98033
Robert Hershberg director 3005 FIRST AVENUE, SEATTLE WA 98121
Peter M Neupert director 13920 SE EASTGATE WAY, STE 300, BELLEVUE WA 98005
Chad M Robins director, officer: CEO and Chairman C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102
Sharon Benzeno officer: Chief Commercial Ofc Imm Med C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102
Susan Bobulsky officer: SVP, Diagnostics, clonoSEQ C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102
Julie Rubinstein officer: President C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102
Francis Lo officer: Chief People Officer C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102
Stacy L Taylor officer: SVP and General Counsel C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVENUE E SUITE 200, SEATTLE WA 98102
Tycho Peterson officer: Chief Financial Officer C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1165 EASTLAKE AVE E, SEATTLE WA 98109
Nitin Sood officer: Chief Commercial Officer, MRD C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102
R Mark Adams officer: Chief Operating Officer C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102
Michael J Pellini director 222 DUTTON MILL RD, WILLISTOWN PA 19380